Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral era.

  • Authors : Wang R; Department of Infectious Diseases, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.; Tan G

Subjects: Hepatitis B*/Hepatitis B*/Hepatitis B*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

  • Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Mar 26; Vol. 150 (3), pp. 158. Date of Electronic Publication: 2024 Mar 26.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335

تفاصيل العنوان

×
Academic Journal

In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients.

  • Authors : Yang J; School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.; National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/complications ; Gastrointestinal Microbiome* ; Liver Neoplasms*

  • Source: Nutrients [Nutrients] 2024 Feb 22; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 22.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation.

  • Authors : Zhang X; Department of Infectious Diseases, Center of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, 130012, China; Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, 130012, China

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Hepatitis B* ; Liver Neoplasms*

  • Source: Virologica Sinica [Virol Sin] 2024 Feb; Vol. 39 (1), pp. 44-55. Date of Electronic Publication: 2023 Oct 11.Publisher: Elsevier B.V. on behalf of KeAi Communications Co. Ltd Country of Publication: Netherlands NLM ID: 101514185 Publication Model: Print-Electronic

تفاصيل العنوان

×
Academic Journal

Regulation of Mitochondrial Metabolism by Hepatitis B Virus.

  • Authors : Li Y; Department of Molecular Microbiology and Immunology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.; Ou JJ

Subjects: Carcinoma, Hepatocellular* ; Liver Neoplasms* ; Hepatitis B*

  • Source: Viruses [Viruses] 2023 Nov 30; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

×
Academic Journal

SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma.

  • Authors : Zhang Y; Department of Laboratory Medicine, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518033, China.; Lao W

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology ; Hepatitis B*/Hepatitis B*/Hepatitis B*/complications

  • Source: BMC cancer [BMC Cancer] 2023 Nov 28; Vol. 23 (1), pp. 1159. Date of Electronic Publication: 2023 Nov 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

×
Academic Journal

Africa Guidelines for Hepatocellular Carcinoma Buildup Process.

  • Authors : Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Medical College at Cornell University, New York, NY.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/therapy

  • Source: JCO global oncology [JCO Glob Oncol] 2023 Sep; Vol. 9, pp. e2300159.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma.

  • Authors : Han Y; Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.; Pan Q

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy

  • Source: Clinical and translational medicine [Clin Transl Med] 2023 May; Vol. 13 (5), pp. e1247.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326

تفاصيل العنوان

×
Academic Journal

Innate Immunity, Inflammation, and Intervention in HBV Infection.

  • Authors : Yang G; Foshan Institute of Medical Microbiology, Foshan 528315, China.; Wan P

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy ; Hepatitis B*

  • Source: Viruses [Viruses] 2022 Oct 17; Vol. 14 (10). Date of Electronic Publication: 2022 Oct 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

×
Academic Journal

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma.

  • Authors : Jiao J; Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.; Jiao D

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology ; Hepatitis B*/Hepatitis B*/Hepatitis B*/complications ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/pathology

  • Source: Aging [Aging (Albany NY)] 2022 Feb 24; Vol. 14 (4), pp. 1879-1890. Date of Electronic Publication: 2022 Feb 24.Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
  • 1-10 of  1,982 نتائج ل ""Li Y""